Evaluation and management of treatment failure and non-response to cardiac myosin inhibitors in obstructive hypertrophic cardiomyopathy
{{output}}
The recent emergence of cardiac myosin inhibitors (CMIs) has established an era of targeted medical therapy for obstructive hypertrophic cardiomyopathy (oHCM), with trials showing decreases in obstructive gradients and improvements in symptoms and exercise cap... ...
